Progrès en Urologie Journal Citation Rate 2026

ISSN 1166-7087 eISSN 2405-5131 Elsevier BV FR

About Progrès en Urologie
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Progrès en Urologie (PEU) is a peer-reviewed academic journal covering Bladder and Urothelial Cancer Treatments and Pelvic floor disorders treatments, published by Elsevier BV in FR, catalogued under ISSN 1166-7087 (e-ISSN 2405-5131). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.00 — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$1910 USD). OpenAlex records 6,395 works and 19,709 citations, with an h-index of 41.

Submission Tips for Progrès en Urologie
  • Budget $1910 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Bladder and Urothelial Cancer Treatments, Pelvic floor disorders treatments, Prostate Cancer Diagnosis and Treatment. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Progrès en Urologie Compares
APC vs Field Avg
-46%
Field avg: $3536

Compared against 20 journals in the same research areas.

ISSN (Print) 1166-7087
ISSN (Online) 2405-5131
Publisher Elsevier BV
Country France
APC / Cost $1910 USD
In-depth profile & metrics

Progrès en Urologie is published by Elsevier BV and based in France. It runs on a subscription or hybrid model with an article-processing charge of USD 1910.

In our subject taxonomy, Progrès en Urologie is classified under Bladder and Urothelial Cancer Treatments, Pelvic floor disorders treatments, Prostate Cancer Diagnosis and Treatment and Ureteral procedures and complications.

Progrès en Urologie is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Research Areas
Links
Frequently Asked Questions about Progrès en Urologie

No, Progrès en Urologie is not an open access journal.

The Article Processing Charge (APC) for Progrès en Urologie is $1910 USD.

Progrès en Urologie is published by Elsevier BV.

Progrès en Urologie shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Progrès en Urologie is 1166-7087. Its electronic ISSN (eISSN) is 2405-5131.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
0.000
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 0.000 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S73435037

Get weekly updates for Bladder and Urothelial Cancer Treatments journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google